Mirum Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Mirum Pharmaceuticals has raised $761M across 3 funding rounds on record, the most recent an undisclosed round of $600M announced in May 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mirum Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: May 2026.
Mirum Pharmaceuticals Funding Rounds
Mirum Pharmaceuticals raised $92.0M in a Post-IPO Equity announced in Aug 2022.
3.3 years later, an undisclosed round of $68.5M was announced in Dec 2025.
5 months later, an undisclosed round of $600M was announced in May 2026.
Mirum Pharmaceuticals Founders and Leadership Team
Contact details for the Mirum Pharmaceuticals team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Mirum Pharmaceuticals Funding Compared to Other Biotechnology Startups
Mirum Pharmaceuticals' latest round of $600M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mirum Pharmaceuticals in Biotechnology and San Diego
Companies Similar to Mirum Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Mirum Pharmaceuticals Funding FAQs
What does Mirum Pharmaceuticals do?
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
How much funding has Mirum Pharmaceuticals raised?
Mirum Pharmaceuticals has raised $761M across 3 rounds on record. The most recent is an undisclosed round of $600M announced in May 2026.
When did Mirum Pharmaceuticals last raise funding?
Mirum Pharmaceuticals' most recent funding round on record is an undisclosed round of $600M, announced in May 2026.
Who founded Mirum Pharmaceuticals?
FundedIQ lists Alejandro Dorenbaum (Founder), Chris Peetz (Founder) at Mirum Pharmaceuticals.
Where is Mirum Pharmaceuticals headquartered?
Mirum Pharmaceuticals is based in San Diego, California, United States.
How many employees does Mirum Pharmaceuticals have?
Mirum Pharmaceuticals is in the 101-250 employee band.
How does Mirum Pharmaceuticals' funding compare to other Biotechnology startups?
Mirum Pharmaceuticals' latest round of $600M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Mirum Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mirum Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.